CAC 40 - PDFSEARCH.IO - Document Search Engine

CAC 40
Results: 401

#	Item
11	PRESS RELEASE For Canadian media only Sanofi to Return Allerject® (epinephrine injection, USP) Rights to kaléo Laval, Qc. - February 23, Sanofi (EURONEXT : SAN and NYSE : SNY) announced today Add to Reading List Source URL: www.aaia.ca Language: English - Date: 2016-03-07 11:32:11 Sanofi Economy of France Business CAC 40 Economy Epinephrine autoinjector Merial Genzyme SNY
12	Chairman of the Board Dave Young INS Dave Young has been a Chairman of the EUEA Board since JanuaryMr. Young is a General Director of INS, a company developing projects in the renewable energy sector as project in Add to Reading List Source URL: euea-energyagency.org Language: English - Date: 2013-02-04 10:54:20 CAC 40 Saint-Gobain Business Economy of France Economy
13	February 5, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By: Add to Reading List Source URL: www.dcat.org Language: English - Date: 2016-02-09 09:31:44 Business Economy Biotechnology CAC 40 Sanofi AstraZeneca Novartis Takeda Pharmaceutical Company Valeant Pharmaceuticals Pharmaceutical industry in China Bausch & Lomb Pharmaceutical industry in India
14	BNP PARIBAS HONG KONG BRANCH Personal Data Privacy Policy Statement 1. Introduction Add to Reading List Source URL: cdn-pays.bnpparibas.com Language: English - Date: 2013-04-25 00:05:13 Finance Financial services Economy Investment banks BNP Paribas Primary dealers CAC 40 Identity management Privacy law Privacy policy Privacy Information privacy
15	GE 2015 fourth quarter performance Financial results & Company highlights January 22, 2016 CAUTION CONCERNING FORWARD-LOOKING STATEMENTS: This document contains "forward-looking statements" – that is, statements relate Add to Reading List Source URL: www.ge.com Language: English - Date: 2016-01-22 06:32:55 Business Economy Alstom CAC 40 General Electric GE Capital GE Industrial Operating cash flow Financial statement
16	RENAULT GRAND MODUS MANUAL WHUS134-PDFRGMM \| 26 Page \| File Size 1,000 KB \| 26 Feb, 2016 COPYRIGHT 2016, ALL RIGHT RESERVED Add to Reading List Source URL: whytheyhate.us Language: English - Date: 2016-08-24 06:18:22 Transport Economy of France CAC 40 Renault Automotive industry Modus Hatchbacks Sedans
17	June 3, Medivation, Sanofi Move Closer to Showdown in Takeover Bid In response to a request by Sanofi, the biopharmaceutical company, Medivation, set a record date of June 1, 2016, for the Add to Reading List Source URL: www.dcat.org Language: English - Date: 2016-06-06 08:58:55 Business Biotechnology Economy Pharmacy CAC 40 Sanofi Patheon Medivation Boehringer Ingelheim AstraZeneca Biosimilar Pharmaceutical industry
18	WeConvene Extel and UKSIF announces the 2016 SRI & Sustainability Survey Results LONDON, July 18th 2016 – WeConvene Extel and the UK Sustainable Investment and Finance Association (UKSIF) announced the results of the 1 Add to Reading List Source URL: uksif.org Language: English - Date: 2016-07-19 06:38:52 Economy Finance Money Investment banks CAC 40 Extel Funds BNP Paribas Socially responsible investing Socit Gnrale Buy side RepRisk
19	A French société anonyme (joint stock company) with share capital of €712,366,974 82, rue Henri Farman – 92130 Issy-les-Moulineaux, France Nanterre Trade and Companies Registry noINCREASE IN ACCOR SHA Add to Reading List Source URL: www.accorhotels-group.com Language: English - Date: 2016-06-21 17:06:24 Economy Finance Hotel chains Money Equity securities Stock market AccorHotels CAC 40 OpenTravel Alliance Eurazeo Stock Joint venture
20	December 4, 2015 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Teva, Takeda Form Generics Joint Venture in Japan Teva Pharmaceu Add to Reading List Source URL: www.dcat.org Language: English - Date: 2016-01-05 08:55:58 Business Economy Pharmaceutical sciences Pharmaceuticals policy Pharmacy Pharmaceutical industry CAC 40 Sanofi Novartis Hikma Pharmaceuticals Teva Pharmaceutical Industries Adalimumab

UPDATE